Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention
Identifieur interne : 001888 ( Istex/Curation ); précédent : 001887; suivant : 001889Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention
Auteurs : Jeffrey J. Popma [États-Unis] ; Nicholas Cox [États-Unis] ; K. Eugene Hauptmann [Allemagne] ; Nicolaus Reifart [Allemagne] ; Renu Virmani ; Khaled Emira [États-Unis] ; Sabina Murphy [États-Unis] ; C. Michael Gibson [États-Unis] ; Eberhard Grube [Allemagne]Source :
- Catheterization and Cardiovascular Interventions [ 1522-1946 ] ; 2002-10.
English descriptors
- KwdEn :
Abstract
Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) and native coronary arteries may be associated with embolization of particulate debris into the distal microcirculation. The FilterWire uses a polyurethane filter bag contained on a radiopaque loop to trap embolic debris during native vessel and SVG intervention. The objectives of this study were to assess the feasibility and safety of the FilterWire during PCI and to examine the size and content of the particulate debris captured during SVG and native vessel intervention. Early angiographic, in‐hospital, and 30‐day clinical outcomes were reviewed in 35 patients with 36 lesions treated with the FilterWire during PCI. Lesions were located in 22 (61%) native coronary arteries and in 14 (39%) SVGs. Multivessel coronary artery disease was present in 75% of patients. Lesions were complex (ACC/AHA complexity B2 or C) in 81% of cases. The FilterWire was successfully delivered and deployed distal to the site of coronary intervention in 92% of lesions, including 95% of native vessels and 82% of SVG lesions. Embolic debris was entrapped in 82% of these cases. The average particulate debris had a mean major axis of 490 μm (range, 45–3,302 μm) and minor axis of 226 μm (range, 33–1,677 μm). Although reduced flow was common (36.1%) when the FilterWire was in place, there were no sustained episodes of abrupt closure and only one (2.8%) patient developed sustained no‐reflow after FilterWire removal. Distal branch vessel embolization was found in four (11.1%) cases. Major adverse cardiac events occurred in 5 (14%) of 35 patients treated with the device, although 2 of these patients were evolving an acute myocardial infarction at the time of the procedure; in patients meeting the prospectively defined inclusion criteria, the major adverse cardiac event was 6%. These results suggest that the FilterWire is a feasible and safe method of collecting particulate debris released during SVG and native vessel coronary intervention. Its benefit over conventional therapy and other distal protection devices is currently under study. Cathet Cardiovasc Intervent 2002;57:125–134. © 2002 Wiley‐Liss, Inc.
Url:
DOI: 10.1002/ccd.10313
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001A05
Links to Exploration step
ISTEX:277C98683DDCBFAB6C9EC1429C50BC9A677EBA2DCuration
No country items
Renu Virmani<affiliation><mods:affiliation>Armed Forces Institute of Pathology, Washington, D.C</mods:affiliation>
<wicri:noCountry code="subField">D.C</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention</title>
<author><name sortKey="Popma, Jeffrey J" sort="Popma, Jeffrey J" uniqKey="Popma J" first="Jeffrey J." last="Popma">Jeffrey J. Popma</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><mods:affiliation>Interventional Cardiology, Brigham and Women's Hospital, 75 Francis Street, L‐2 Catheterization Laboratory, Boston, MA 02115</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Interventional Cardiology, Brigham and Women's Hospital, 75 Francis Street, L‐2 Catheterization Laboratory, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cox, Nicholas" sort="Cox, Nicholas" uniqKey="Cox N" first="Nicholas" last="Cox">Nicholas Cox</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hauptmann, K Eugene" sort="Hauptmann, K Eugene" uniqKey="Hauptmann K" first="K. Eugene" last="Hauptmann">K. Eugene Hauptmann</name>
<affiliation wicri:level="1"><mods:affiliation>Krankenhaus D. Barmh Bruder, Trier, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Krankenhaus D. Barmh Bruder, Trier</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Reifart, Nicolaus" sort="Reifart, Nicolaus" uniqKey="Reifart N" first="Nicolaus" last="Reifart">Nicolaus Reifart</name>
<affiliation wicri:level="1"><mods:affiliation>Kardiologisches Institut Main‐Taunus, Taunus, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Kardiologisches Institut Main‐Taunus, Taunus</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Virmani, Renu" sort="Virmani, Renu" uniqKey="Virmani R" first="Renu" last="Virmani">Renu Virmani</name>
<affiliation><mods:affiliation>Armed Forces Institute of Pathology, Washington, D.C</mods:affiliation>
<wicri:noCountry code="subField">D.C</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Emira, Khaled" sort="Emira, Khaled" uniqKey="Emira K" first="Khaled" last="Emira">Khaled Emira</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Murphy, Sabina" sort="Murphy, Sabina" uniqKey="Murphy S" first="Sabina" last="Murphy">Sabina Murphy</name>
<affiliation wicri:level="2"><mods:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Gibson, C Michael" sort="Gibson, C Michael" uniqKey="Gibson C" first="C. Michael" last="Gibson">C. Michael Gibson</name>
<affiliation wicri:level="2"><mods:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Grube, Eberhard" sort="Grube, Eberhard" uniqKey="Grube E" first="Eberhard" last="Grube">Eberhard Grube</name>
<affiliation wicri:level="1"><mods:affiliation>Heart Center, Siegburg, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Heart Center, Siegburg</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:277C98683DDCBFAB6C9EC1429C50BC9A677EBA2D</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1002/ccd.10313</idno>
<idno type="url">https://api.istex.fr/document/277C98683DDCBFAB6C9EC1429C50BC9A677EBA2D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A05</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001A05</idno>
<idno type="wicri:Area/Istex/Curation">001888</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention</title>
<author><name sortKey="Popma, Jeffrey J" sort="Popma, Jeffrey J" uniqKey="Popma J" first="Jeffrey J." last="Popma">Jeffrey J. Popma</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><mods:affiliation>Interventional Cardiology, Brigham and Women's Hospital, 75 Francis Street, L‐2 Catheterization Laboratory, Boston, MA 02115</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Interventional Cardiology, Brigham and Women's Hospital, 75 Francis Street, L‐2 Catheterization Laboratory, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Cox, Nicholas" sort="Cox, Nicholas" uniqKey="Cox N" first="Nicholas" last="Cox">Nicholas Cox</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hauptmann, K Eugene" sort="Hauptmann, K Eugene" uniqKey="Hauptmann K" first="K. Eugene" last="Hauptmann">K. Eugene Hauptmann</name>
<affiliation wicri:level="1"><mods:affiliation>Krankenhaus D. Barmh Bruder, Trier, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Krankenhaus D. Barmh Bruder, Trier</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Reifart, Nicolaus" sort="Reifart, Nicolaus" uniqKey="Reifart N" first="Nicolaus" last="Reifart">Nicolaus Reifart</name>
<affiliation wicri:level="1"><mods:affiliation>Kardiologisches Institut Main‐Taunus, Taunus, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Kardiologisches Institut Main‐Taunus, Taunus</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Virmani, Renu" sort="Virmani, Renu" uniqKey="Virmani R" first="Renu" last="Virmani">Renu Virmani</name>
<affiliation><mods:affiliation>Armed Forces Institute of Pathology, Washington, D.C</mods:affiliation>
<wicri:noCountry code="subField">D.C</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Emira, Khaled" sort="Emira, Khaled" uniqKey="Emira K" first="Khaled" last="Emira">Khaled Emira</name>
<affiliation wicri:level="2"><mods:affiliation>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Internal Medicine, Cardiovascular Divisions, Brigham and Women's Hospital, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Murphy, Sabina" sort="Murphy, Sabina" uniqKey="Murphy S" first="Sabina" last="Murphy">Sabina Murphy</name>
<affiliation wicri:level="2"><mods:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Gibson, C Michael" sort="Gibson, C Michael" uniqKey="Gibson C" first="C. Michael" last="Gibson">C. Michael Gibson</name>
<affiliation wicri:level="2"><mods:affiliation>Harvard Clinical Research Institute, Boston, Massachusetts</mods:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Harvard Clinical Research Institute, Boston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Grube, Eberhard" sort="Grube, Eberhard" uniqKey="Grube E" first="Eberhard" last="Grube">Eberhard Grube</name>
<affiliation wicri:level="1"><mods:affiliation>Heart Center, Siegburg, Germany</mods:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Heart Center, Siegburg</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Catheterization and Cardiovascular Interventions</title>
<title level="j" type="abbrev">Cathet. Cardiovasc. Intervent.</title>
<idno type="ISSN">1522-1946</idno>
<idno type="eISSN">1522-726X</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="2002-10">2002-10</date>
<biblScope unit="volume">57</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="125">125</biblScope>
<biblScope unit="page" to="134">134</biblScope>
</imprint>
<idno type="ISSN">1522-1946</idno>
</series>
<idno type="istex">277C98683DDCBFAB6C9EC1429C50BC9A677EBA2D</idno>
<idno type="DOI">10.1002/ccd.10313</idno>
<idno type="ArticleID">CCD10313</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1522-1946</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>distal protection</term>
<term>saphenous vein graft</term>
<term>stenting</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Percutaneous coronary intervention (PCI) of saphenous vein grafts (SVG) and native coronary arteries may be associated with embolization of particulate debris into the distal microcirculation. The FilterWire uses a polyurethane filter bag contained on a radiopaque loop to trap embolic debris during native vessel and SVG intervention. The objectives of this study were to assess the feasibility and safety of the FilterWire during PCI and to examine the size and content of the particulate debris captured during SVG and native vessel intervention. Early angiographic, in‐hospital, and 30‐day clinical outcomes were reviewed in 35 patients with 36 lesions treated with the FilterWire during PCI. Lesions were located in 22 (61%) native coronary arteries and in 14 (39%) SVGs. Multivessel coronary artery disease was present in 75% of patients. Lesions were complex (ACC/AHA complexity B2 or C) in 81% of cases. The FilterWire was successfully delivered and deployed distal to the site of coronary intervention in 92% of lesions, including 95% of native vessels and 82% of SVG lesions. Embolic debris was entrapped in 82% of these cases. The average particulate debris had a mean major axis of 490 μm (range, 45–3,302 μm) and minor axis of 226 μm (range, 33–1,677 μm). Although reduced flow was common (36.1%) when the FilterWire was in place, there were no sustained episodes of abrupt closure and only one (2.8%) patient developed sustained no‐reflow after FilterWire removal. Distal branch vessel embolization was found in four (11.1%) cases. Major adverse cardiac events occurred in 5 (14%) of 35 patients treated with the device, although 2 of these patients were evolving an acute myocardial infarction at the time of the procedure; in patients meeting the prospectively defined inclusion criteria, the major adverse cardiac event was 6%. These results suggest that the FilterWire is a feasible and safe method of collecting particulate debris released during SVG and native vessel coronary intervention. Its benefit over conventional therapy and other distal protection devices is currently under study. Cathet Cardiovasc Intervent 2002;57:125–134. © 2002 Wiley‐Liss, Inc.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001888 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001888 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Rhénanie |area= UnivTrevesV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:277C98683DDCBFAB6C9EC1429C50BC9A677EBA2D |texte= Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention }}
![]() | This area was generated with Dilib version V0.6.31. | ![]() |